RepliCel Life Sciences Цена / балансовая стоимость

Что обозначает Цена / балансовая стоимость в RepliCel Life Sciences?

Цена / балансовая стоимость RepliCel Life Sciences, Inc. является -0.77

Какое определение для Цена / балансовая стоимость?



Отношение рыночной цены акции к её балансовой учётной стоимости представляет собой соотношение между стоимостью акций компании и балансовой стоимостью на акцию.

The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).

The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).

P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.

Цена / балансовая стоимость компаний в Health Care сектор на TSXV по сравнению с RepliCel Life Sciences

Что делает RepliCel Life Sciences?

RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.

Компании с цена / балансовая стоимость похож на RepliCel Life Sciences



  • Gayatri Sugars имеет Цена / балансовая стоимость из -0.77
  • CVR Medical имеет Цена / балансовая стоимость из -0.77
  • QDM International имеет Цена / балансовая стоимость из -0.77
  • Collaborate имеет Цена / балансовая стоимость из -0.77
  • TrustBIX имеет Цена / балансовая стоимость из -0.77
  • Starlite Components имеет Цена / балансовая стоимость из -0.77
  • RepliCel Life Sciences имеет Цена / балансовая стоимость из -0.77
  • Bitcoin Well Inc имеет Цена / балансовая стоимость из -0.76
  • Wheeler Real Estate Investment Trust Inc имеет Цена / балансовая стоимость из -0.76
  • Pioneer Distilleries имеет Цена / балансовая стоимость из -0.76
  • Maple Leaf Green World имеет Цена / балансовая стоимость из -0.76
  • Management Consulting PLC имеет Цена / балансовая стоимость из -0.75
  • Alok Industries имеет Цена / балансовая стоимость из -0.75